Ambroxol Hydrochloride Injection

  • Favorite
Baiyu Pharmaceutical Co., Ltd.

Business Type:Manufacturer

Country/Region:China

Ddu Verified

HOT Rank

6/10

Product Information

  • Indication:This product is indicated for acute and chronic lung diseases accompanied by abnormal secretion of sputum and poor sputum function, the expectorant treatment for chronic bronchitis exacerbation, asthm
  • Specification:2ml: 15mg; 4ml: 30mg
  • Dosage Form:Injection
  • Active Ingredients:Ambroxol Hydrochloride
  • Route of Administration:Intravenous Drip
  • Shelf Life:3 years
  • Storage:Sealed
  • Package:Brown glass ampoules, 10 ampoules/box, 100 boxes/carton (2ml:15mg), 60 boxes/carton (4ml:30mg) (Can be customized)
  • Place of Origin:China
  • Qualification:FDA

Description

Except for the usual indications, it can be widely used for nebulization in China.

Active ingredient: Ambroxol Hydrochloride

Description: A colorless clear liquid.

Dosage form: liquid injection

Strength: 2ml: 15mg; 4ml: 30mg

Storage: Sealed and kept under 30.

Packaging: Brown glass ampoules, 10 ampoules/box, 100 boxes/carton (2ml:15mg), 60 boxes/carton (4ml:30mg) (Can be customized)

Shelf life: 24 months

Indications:

This product is indicated for acute and chronic lung diseases accompanied by abnormal secretion of sputum and poor sputum function, the expectorant treatment for chronic bronchitis exacerbation, asthmatic bronchitis and bronchial asthma for example. It can also be used for prevention of pulmonary complications after surgery and treatment of infant respiratory distress syndrome (IRDS) in preterm and neonates.

Dosage and administration:

Prevention and treatment

Adults and children over 12 years old: 2-3 times a day, 15 mg each time, slow intravenous infusion; increase to 30 mg each time for severe cases.

Children 6-12 years: 2-3 times a day, 15mg each time.

Children aged 2-6: 3 times a day, 7.5 mg each time.

Children under 2 years: 2 times a day, 7.5mg each time.

All are slow intravenous infusion.

Treatment of infant respiratory distress syndrome (IRDS): The total daily dose is calculated based on infant weight and 30 mg/kg is administered in 4 divided doses.

Syringe pumps should be used for administration with at least 5 minutes of intravenous injection duration.

The injection can also be used intravenously with glucose, fructose, saline or Ringer's solution.

Precaution:

Do not mix this product with other solutions having a pH greater than 6.3, as the increase in pH will cause precipitation of free base.

Pregnant and lactating women medication

Preclinical testing and extensive clinical experience after 28 weeks of gestation show no adverse effects on pregnancy. However, drugs should be used with caution during pregnancy, especially during the first trimester of pregnancy. The drug can enter the milk, but the therapeutic dose should have no effect on the baby.

Children medication: Refer to dosage and administration.

Elderly medication: No special precautions.

Overdose: So far there have been no reports of symptoms on overdose of this medicine.


You Might Also Like
Change a group
Inquiry Cart(0)